Device Trial Radar · NCT05555030
COVID-19 iCura SARS-CoV-2 Ag OTC: Clinical Evaluation
Last checked: Nov 20, 2026Latest source record: Feb 15, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Aug 4, 2022
Primary completion
Dec 20, 2022
Study completion Dec 20, 2022
Sponsor
- Lead sponsor
- New Day DiagnosticsResearch network
- Sponsor type
- Research network
- Collaborators
- Paragon Rx Clinical, Inc.; iCura Diagnostics, LLC
- First posted
- Sep 26, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
SARS-CoV-2 rapid antigen over the counter clinical performance evaluation.
Conditions
- SARS-CoV-2 Infection
- COVID-19
Interventions
iCura COVID-19 Antigen Rapid Home TestDevice
Candidate Ag self-test kit anterior nasal specimen collection and testing will be done under the supervision of qualified site personnel in person. Comparator NP samples shall be collected at least 15 minutes prior to Ag samples with at least 15 minutes between nasal collections including collections that may occur prior to study enrollment. Comparator samples will be collected first by qualified personnel at a study site or physician's office using an FDA authorized nasopharyngeal swab collection kit and SARS-CoV-2 molecular assay.
RT-PCR TestDiagnostic test
High sensitivity RT-PCR COVID-19 Test
Primary outcomes
What the sponsor says the trial is designed to measure.
- Positive Percent AgreementTime frame: 3 months
1 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Paragon
Anaheim, California
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.